In summary, it is challenging to include chalcones with multiple anticancer effects, including inhibitory action on some ABC transporters, in future potential tumor treatment to achieve high antitumor efficacy, safety, and a reduction in drug resistance. This evidence concerns the gene ABCG2 and neoplasm.